- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 655066 (low s.c. dose)
Total 1927 results
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; AIDS Clinical Trials... and other collaboratorsCompletedCovid19 | CoronavirusUnited States, Argentina, Brazil, Guatemala, Mexico, Philippines, Puerto Rico, South Africa, Canada
-
Centre de Recherche de l'Institut Universitaire...RecruitingStroke | Thrombosis | Bleeding | Left Atrial Appendage Closure | TIACanada
-
Michael Pulsipher, MDActive, not recruitingSevere Aplastic AnemiaUnited States
-
First Affiliated Hospital of Zhejiang UniversityWenzhou Central HospitalUnknownHIV/AIDS | Cryptococcal MeningitisChina
-
Boston Children's HospitalNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaboratorsRecruitingSevere Aplastic AnemiaUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseChina, Argentina, Taiwan, Chile
-
Fondazione per la Medicina PersonalizzataActive, not recruitingBreast Cancer | Non Small Cell Lung Cancer | Gastrointestinal Cancer | Other CancerItaly
-
Fred Hutchinson Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHot Flashes | Menopause | Vasomotor DisturbanceUnited States
-
Hoffmann-La RocheActive, not recruitingInflammatory Breast Cancer | Early Breast Cancer | Locally Advanced Breast CancerCanada, Croatia, Spain, Argentina, Mexico, Korea, Republic of, Bosnia and Herzegovina, Brazil, Costa Rica, Turkey, Singapore, Bulgaria, South Africa, India, Peru, Kenya, Chile
-
The George InstituteNational Health and Medical Research Council, Australia; Takeda; Conselho Nacional... and other collaboratorsCompletedIschemic Stroke | High Blood PressureAustralia
-
Sohag UniversityNot yet recruitingPatient With Anterior Myocardial InfarctionEgypt
-
University of DundeeAstraZeneca; NHS TaysideCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
WiSP Wissenschaftlicher Service Pharma GmbHCompleted
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)Belgium, Italy, Spain, Saudi Arabia, Turkey, United Kingdom, Germany, Greece, Canada, Austria, France, Israel, Netherlands, Sweden, Switzerland, Korea, Republic of, Bulgaria, Japan, Norway, Czechia, Russian Federation, Jordan, Hungary, Ind... and more
-
M.D. Anderson Cancer CenterBayerTerminated
-
Felix GutierrezHospital Clinic of Barcelona; Hospital General Universitario Elche; Germans Trias... and other collaboratorsRecruiting
-
Xi'an International Medical Center HospitalCompleted
-
Aalborg University HospitalRecruitingType 2 Diabetes | Osteoporosis | Diabetic Neuropathy Peripheral | Bone Disease | Autonomic Neuropathy, DiabeticDenmark
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedClassic Hodgkin Lymphoma | Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 | Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8United States
-
University of OxfordBill and Melinda Gates Foundation; Department for International Development... and other collaboratorsRecruitingSevere Acute Respiratory SyndromeGhana, Indonesia, Nepal, South Africa, United Kingdom, Vietnam, India
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Recruiting
-
Fundacion para la Investigacion Biomedica del Hospital...University of Alcala; Hospital Universitario Ramon y Cajal; Instituto de Salud... and other collaboratorsRecruitingPolycystic Ovary Syndrome | Hyperandrogenism | Type 1 Diabetes | Hirsutism | Oligomenorrhea | Ovulation DisorderSpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingHematopoietic and Lymphoid System NeoplasmUnited States
-
University of ArkansasNational Institutes of Health (NIH); Ortho Biotech Clinical Affairs, L.L.C.Completed
-
Case Comprehensive Cancer CenterCompletedRenal Cell Cancer | Stage IV Renal Cell CancerUnited States
-
National Cancer Institute (NCI)CompletedAdvanced Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Advanced Sarcomatoid Renal Cell CarcinomaUnited States
-
David Bond, MDBristol-Myers SquibbActive, not recruitingDiffuse Large B-Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | Transformed Non-Hodgkin Lymphoma | Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma | Ann Arbor Stage... and other conditionsUnited States
-
Genentech, Inc.CompletedAdvanced Unresectable or Metastatic Solid MalignancyUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)CompletedAdvanced Malignant Neoplasm | Dermatologic ComplicationUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Active, not recruitingB-Cell Non-Hodgkin LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | CD19 PositiveUnited States
-
Northwestern UniversityBristol-Myers Squibb; National Cancer Institute (NCI)SuspendedB-Cell Non-Hodgkin Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | CD20 Positive | Aggressive Non-Hodgkin Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma Unclassifiable | Intravascular Large B-Cell Lymphoma | T-Cell/Histiocyte-Rich...United States
-
Joseph TuscanoNational Cancer Institute (NCI); ADC Therapeutics S.A.RecruitingHigh Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Double-Expressor Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsUnited States
-
OHSU Knight Cancer InstituteAbbVie; Oregon Health and Science UniversityRecruitingB Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic Leukemia | Recurrent Mixed Phenotype Acute Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Mixed Phenotype Acute LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingAnn Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell LymphomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedGrade 3b Follicular Lymphoma | Stage III Follicular Lymphoma | Composite Lymphoma | Stage I Diffuse Large B-Cell Lymphoma | Stage I Follicular Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage II Follicular Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell Lymphoma and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States
-
University of WashingtonIncyte CorporationRecruitingB Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingMantle Cell LymphomaUnited States
-
Yazeed SawalhaRecruitingZanubrutinib in Combination With R-CHOP (ZaR-CHOP) for Newly Diagnosed Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Ann Arbor Stage II Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruitingDiffuse Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise Specified | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements | Diffuse Large B-Cell Lymphoma... and other conditionsUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnRecurrent Adult Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic Lymphoma | B Lymphoblastic Lymphoma | Recurrent T Lymphoblastic Leukemia/Lymphoma | Refractory T Lymphoblastic Lymphoma | T Acute Lymphoblastic Leukemia | T...United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedDiffuse Large B-Cell Lymphoma UnclassifiableUnited States
-
National Cancer Institute (NCI)CompletedHIV Infection | Recurrent Grade 3 Follicular Lymphoma | Plasmablastic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Primary Effusion Lymphoma | AIDS-Related Primary Effusion Lymphoma | Ann Arbor Stage I Diffuse Large B-Cell Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruiting
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States